147 related articles for article (PubMed ID: 20208474)
1. Iloperidone (Fanapt)--another second-generation antipsychotic.
Med Lett Drugs Ther; 2010 Feb; 52(1332):13-4; quiz 17. PubMed ID: 20208474
[No Abstract] [Full Text] [Related]
2. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion.
Citrome L
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1551-64. PubMed ID: 21034370
[TBL] [Abstract][Full Text] [Related]
3. Iloperidone for the management of adults with schizophrenia.
Crabtree BL; Montgomery J
Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
[TBL] [Abstract][Full Text] [Related]
4. ACS chemical neuroscience molecule spotlight on Fanapt.
Hopkins CR
ACS Chem Neurosci; 2010 Jun; 1(6):410. PubMed ID: 22778835
[TBL] [Abstract][Full Text] [Related]
5. Iloperidone for the treatment of schizophrenia: an updated clinical review.
Weiden PJ
Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):34-44. PubMed ID: 22453868
[TBL] [Abstract][Full Text] [Related]
6. Iloperidone for schizophrenia.
Rado J; Janicak PG
Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
[TBL] [Abstract][Full Text] [Related]
7. Iloperidone: a new option for the treatment of schizophrenia.
Cutler AJ
Expert Rev Neurother; 2009 Dec; 9(12):1727-41. PubMed ID: 19951132
[TBL] [Abstract][Full Text] [Related]
8. Iloperidone: A new drug for the treatment of schizophrenia.
Arif SA; Mitchell MM
Am J Health Syst Pharm; 2011 Feb; 68(4):301-8. PubMed ID: 21289324
[TBL] [Abstract][Full Text] [Related]
9. FDA approved new drug bulletin: risperidone (risperdal).
RN; 1994 Jun; 57(6):45-6. PubMed ID: 7526438
[No Abstract] [Full Text] [Related]
10. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
Potkin SG; Litman RE; Torres R; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S4-11. PubMed ID: 18334911
[TBL] [Abstract][Full Text] [Related]
11. Risperidone: integrating research and practice.
Addington D
Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628
[TBL] [Abstract][Full Text] [Related]
12. An assessment of iloperidone for the treatment of schizophrenia.
Jain KK
Expert Opin Investig Drugs; 2000 Dec; 9(12):2935-43. PubMed ID: 11093363
[TBL] [Abstract][Full Text] [Related]
13. New advances in the treatment of schizophrenia. Introduction.
Potkin SG
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S1-3. PubMed ID: 18334907
[No Abstract] [Full Text] [Related]
14. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
15. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
[TBL] [Abstract][Full Text] [Related]
16. Risperidone: review of its pharmacology and therapeutic use in schizophrenia.
Gupta S; Black DW; Smith DA
Ann Clin Psychiatry; 1994 Sep; 6(3):173-80. PubMed ID: 7533585
[TBL] [Abstract][Full Text] [Related]
17. Risperidone and remoxipride for schizophrenia.
Drug Ther Bull; 1993 Dec; 31(26):101-2. PubMed ID: 7508364
[No Abstract] [Full Text] [Related]
18. Risperidone for chronic schizophrenia.
Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
[No Abstract] [Full Text] [Related]
19. Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
Thompson A; Lavedan C; Volpi S
Psychiatry Res; 2010 Feb; 175(3):271-3. PubMed ID: 20045196
[TBL] [Abstract][Full Text] [Related]
20. Prospects for pharmacotherapy of schizophrenia.
Pickar D
Lancet; 1995 Mar; 345(8949):557-62. PubMed ID: 7539875
[No Abstract] [Full Text] [Related]
[Next] [New Search]